Research database

SVF Research Library

Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 25 matching records.

Search the database

Evidence

Sort

25 results — page 1 of 2

Level ASystematic ReviewEurope PMC
Review: progression and heterogeneity of multiple sources of mesenchymal stromal cells for the treatment of rheumatoid arthritis
Systematic Review on Chronic Inflammation, Immune Modulation, Autoimmune Research, published in Stem Cell Res Ther (2025) — summary generated from the PubMed abstract.
2025
Stem Cell Res Ther
Level DLaboratory StudyPubMed
Single-cell RNA sequencing reveals the heterogeneity of adipose tissue-derived mesenchymal stem cells under chondrogenic induction.
Laboratory Study, published in BMB Rep (2024) — summary generated from the PubMed abstract.
2024
BMB Rep
Level BClinical TrialPubMed
Heterogeneity of mesenchymal stem cells as a limiting factor in their clinical application to inflammatory bowel disease in dogs and cats.
Clinical Trial on Chronic Inflammation, Immune Modulation, published in Vet J (2024) — summary generated from the PubMed abstract.
2024
Vet J
Level DNarrative ReviewEurope PMC
An Overview of Mesenchymal Stem Cell Heterogeneity and Concentration
Narrative Review on Immune Modulation, published in Pharmaceuticals (Basel) (2024) — summary generated from the PubMed abstract.
2024
Pharmaceuticals (Basel)
25 citations
Level DLaboratory StudyPubMed
Deciphering the Heterogeneity Landscape of Mesenchymal Stem/Stromal Cell-Derived Extracellular Vesicles for Precise Selection in Translational Medicine.
Laboratory Study, published in Adv Healthc Mater (2023) — summary generated from the PubMed abstract.
2023
Adv Healthc Mater
Level DLaboratory StudyPubMed
Transcriptomic Heterogeneity of Human Mesenchymal Stem Cells Derived from Bone Marrow, Dental Pulp, Adipose Tissue, and Umbilical Cord.
Laboratory Study, published in Cell Reprogram (2023) — summary generated from the PubMed abstract.
2023
Cell Reprogram
Level DAnimal StudyPubMed
Convergent alteration of the mesenchymal stem cell heterogeneity in adipose tissue during aging.
Animal Study on Chronic Inflammation, published in FASEB J (2023) — summary generated from the PubMed abstract.
2023
FASEB J
5 citations
Level DLaboratory StudyPubMed
Morphological heterogeneity description enabled early and parallel non-invasive prediction of T-cell proliferation inhibitory potency and growth rate for facilitating donor selection of human mesenchymal stem cells.
Laboratory Study on Immune Modulation, published in Inflamm Regen (2022) — summary generated from the PubMed abstract.
2022
Inflamm Regen
6 citations
Level CProspective StudyPubMed
Mucin 5AC-Mediated CD44/ITGB1 Clustering Mobilizes Adipose-Derived Mesenchymal Stem Cells to Modulate Pancreatic Cancer Stromal Heterogeneity.
Prospective Study on Face & Skin, published in Gastroenterology (2022) — summary generated from the PubMed abstract.
2022
Gastroenterology
25 citations
Level DNarrative ReviewEurope PMC
Functional heterogeneity of mesenchymal stem cells from natural niches to culture conditions: implications for further clinical uses
Narrative Review on Autoimmune Research, published in Cell Mol Life Sci (2021) — summary generated from the PubMed abstract.
2021
Cell Mol Life Sci
236 citations
Level DNarrative ReviewEurope PMC
Heterogeneity of mesenchymal stem cells in cartilage regeneration: from characterization to application
Narrative Review on Cartilage Damage, published in NPJ Regen Med (2021) — summary generated from the PubMed abstract.
2021
NPJ Regen Med
137 citations
Level DNarrative ReviewEurope PMC
Cellular Heterogeneity of Mesenchymal Stem/Stromal Cells in the Bone Marrow
Narrative Review on Face & Skin, published in Front Cell Dev Biol (2021) — summary generated from the PubMed abstract.
2021
Front Cell Dev Biol
49 citations
Level DLaboratory StudyPubMed
Single-cell transcriptomic sequencing analyses of cell heterogeneity during osteogenesis of human adipose-derived mesenchymal stem cells.
Laboratory Study, published in Stem Cells (2021) — summary generated from the PubMed abstract.
2021
Stem Cells
17 citations
Level AMeta-analysisPubMed
Human Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells Acquire Rejuvenation and Reduced Heterogeneity.
Meta-analysis on Ligament Injury, published in Front Cell Dev Biol (2021) — summary generated from the PubMed abstract.
2021
Front Cell Dev Biol
Level DLaboratory StudyPubMed
Single-cell transcriptome atlas of human mesenchymal stem cells exploring cellular heterogeneity.
Laboratory Study with a reported sample of 3, published in Clin Transl Med (2021) — summary generated from the PubMed abstract.
2021
Clin Transl Med
n = 3
Level DLaboratory StudyPubMed
Single-cell RNA-seq highlights heterogeneity in human primary Wharton's jelly mesenchymal stem/stromal cells cultured in vitro.
Laboratory Study on Chronic Wound, Immune Modulation, published in Stem Cell Res Ther (2020) — summary generated from the PubMed abstract.
2020
Stem Cell Res Ther
84 citations
Level DAnimal StudyPubMed
Single-cell RNA sequencing of equine mesenchymal stromal cells from primary donor-matched tissue sources reveals functional heterogeneity in immune modulation and cell motility.
Animal Study on Immune Modulation, published in Stem Cell Res Ther (2020) — summary generated from the PubMed abstract.
2020
Stem Cell Res Ther
Level DNarrative ReviewEurope PMC
Cellular Heterogeneity of Pancreatic Stellate Cells, Mesenchymal Stem Cells, and Cancer-Associated Fibroblasts in Pancreatic Cancer
Narrative Review, published in Cancers (Basel) (2020) — summary generated from the PubMed abstract.
2020
Cancers (Basel)
46 citations
Level DNarrative ReviewEurope PMC
Nomenclature and heterogeneity: consequences for the use of mesenchymal stem cells in regenerative medicine
Narrative Review on Chronic Inflammation, Immune Modulation, published in Regen Med (2019) — summary generated from the PubMed abstract.
2019
Regen Med
74 citations
Level DLaboratory StudyPubMed
New insights into the heterogeneity and functional diversity of human mesenchymal stem cells.
Laboratory Study on Immune Modulation, published in Biomed Mater Eng (2017) — summary generated from the PubMed abstract.
2017
Biomed Mater Eng
Level ASystematic ReviewPubMed
Heterogeneity in Studies of Mesenchymal Stromal Cells to Treat or Prevent Graft-versus-Host Disease: A Scoping Review of the Evidence.
Systematic Review with a reported sample of 507 on Immune Modulation, published in Biol Blood Marrow Transplant (2016) — summary generated from the PubMed abstract.
2016
Biol Blood Marrow Transplant
n = 507
Level DLaboratory StudyPubMed
Heterogeneity of proangiogenic features in mesenchymal stem cells derived from bone marrow, adipose tissue, umbilical cord, and placenta.
Laboratory Study, published in Stem Cell Res Ther (2016) — summary generated from the PubMed abstract.
2016
Stem Cell Res Ther
Level DAnimal StudyPubMed
Cytogenetic heterogeneity and their serial dynamic changes during acquisition of cytogenetic aberrations in cultured mesenchymal stem cells.
Animal Study, published in Mutat Res (2015) — summary generated from the PubMed abstract.
2015
Mutat Res
Level DLaboratory StudyPubMed
Heterogeneity of baseline neural marker expression by undifferentiated mesenchymal stem cells may be correlated to donor age.
Laboratory Study, published in J Biotechnol (2014) — summary generated from the PubMed abstract.
2014
J Biotechnol

In-depth reviewed studies (full Thai translation)

Evidence system

SVF Research Library

Review: progression and heterogeneity of multiple sources of mesenchymal stromal cells for the treatment of rheumatoid arthritis

Single-cell RNA sequencing reveals the heterogeneity of adipose tissue-derived mesenchymal stem cells under chondrogenic induction.

Heterogeneity of mesenchymal stem cells as a limiting factor in their clinical application to inflammatory bowel disease in dogs and cats.

An Overview of Mesenchymal Stem Cell Heterogeneity and Concentration

Deciphering the Heterogeneity Landscape of Mesenchymal Stem/Stromal Cell-Derived Extracellular Vesicles for Precise Selection in Translational Medicine.

Transcriptomic Heterogeneity of Human Mesenchymal Stem Cells Derived from Bone Marrow, Dental Pulp, Adipose Tissue, and Umbilical Cord.

Convergent alteration of the mesenchymal stem cell heterogeneity in adipose tissue during aging.

Morphological heterogeneity description enabled early and parallel non-invasive prediction of T-cell proliferation inhibitory potency and growth rate for facilitating donor selection of human mesenchymal stem cells.

Mucin 5AC-Mediated CD44/ITGB1 Clustering Mobilizes Adipose-Derived Mesenchymal Stem Cells to Modulate Pancreatic Cancer Stromal Heterogeneity.

Functional heterogeneity of mesenchymal stem cells from natural niches to culture conditions: implications for further clinical uses

Heterogeneity of mesenchymal stem cells in cartilage regeneration: from characterization to application

Cellular Heterogeneity of Mesenchymal Stem/Stromal Cells in the Bone Marrow

Single-cell transcriptomic sequencing analyses of cell heterogeneity during osteogenesis of human adipose-derived mesenchymal stem cells.

Human Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells Acquire Rejuvenation and Reduced Heterogeneity.

Single-cell transcriptome atlas of human mesenchymal stem cells exploring cellular heterogeneity.

Single-cell RNA-seq highlights heterogeneity in human primary Wharton's jelly mesenchymal stem/stromal cells cultured in vitro.

Single-cell RNA sequencing of equine mesenchymal stromal cells from primary donor-matched tissue sources reveals functional heterogeneity in immune modulation and cell motility.

Cellular Heterogeneity of Pancreatic Stellate Cells, Mesenchymal Stem Cells, and Cancer-Associated Fibroblasts in Pancreatic Cancer

Nomenclature and heterogeneity: consequences for the use of mesenchymal stem cells in regenerative medicine

New insights into the heterogeneity and functional diversity of human mesenchymal stem cells.

Heterogeneity in Studies of Mesenchymal Stromal Cells to Treat or Prevent Graft-versus-Host Disease: A Scoping Review of the Evidence.

Heterogeneity of proangiogenic features in mesenchymal stem cells derived from bone marrow, adipose tissue, umbilical cord, and placenta.

Cytogenetic heterogeneity and their serial dynamic changes during acquisition of cytogenetic aberrations in cultured mesenchymal stem cells.

Heterogeneity of baseline neural marker expression by undifferentiated mesenchymal stem cells may be correlated to donor age.

In-depth reviewed studies (full Thai translation)

Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial

Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials

Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis